Statins and familial hypercholesterolaemia. by Neil, A, Humphries, SE

Developing and applying clinically useful approaches to identify individuals with familial hypercholesterolemia in the UK by Humphries, SE, Neil, H

Effect of statin treatment for familial hypercholesterolaemia on life assurance: results of consecutive surveys in 1990 and 2002. by Neil, H, Hammond, T, Mant, D, Humphries, SE

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. by Marks, D, Thorogood, M, Neil, H, Humphries, SE

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia. by Minhas, R, Humphries, SE, Qureshi, N, Neil, H

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. by Neil, H, Hammond, T, Huxley, R, Matthews, DR, Humphries, SE

In search of genetic precision. by Humphries, SE, Hawe, E, Dhamrait, S, Miller, G, Talmud, P

Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes. by Marks, D, Thorogood, M, Neil, S, Humphries, SE, Neil, H

Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study. by Peacock, R, Karpe, F, Talmud, P, Hamsten, A, Humphries, SE

Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening. by Marks, D, Thorogood, M, Neil, H, Wonderling, D, Humphries, SE

Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study. by Huxley, R, Hawkins, M, Humphries, SE, Karpe, F, Neil, H

A variant in the gene for a human mitochondrial uncoupling protein is associated with left ventricular mass after training by Dhamrait, S, Jones, A, Brull, D, Myerson, S, World, M, Pennell, D, Humphries, SE

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. by Marks, D, Wonderling, D, Thorogood, M, Lambert, H, Humphries, SE, Neil, H

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. by Marks, D, Wonderling, D, Thorogood, M, Lambert, H, Humphries, SE, Neil, H

The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men. by Scartezini, M, Hubbart, C, Whittall, R, Cooper, J, Neil, A, Humphries, SE

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study. by Neil, H, Hawkins, M, Durrington, P, Betteridge, D, Capps, N, Humphries, SE

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study. by Neil, H, Huxley, R, Hawkins, M, Durrington, P, Betteridge, D, Humphries, SE

Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan. by Myerson, S, Montgomery, H, Whittingham, M, Jubb, M, World, M, Humphries, SE, Pennell, D

CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT by Seed, M, Roughton, M, Nair, D, Pederson, K, Wang, T, Neil, A, Humphries, SE

Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia. by Nherera, L, Calvert, N, Demott, K, Humphries, SE, Neil, H, Minhas, R, Thorogood, M